Search

Your search keyword '"Piotrowski, W."' showing total 633 results

Search Constraints

Start Over You searched for: Author "Piotrowski, W." Remove constraint Author: "Piotrowski, W."
633 results on '"Piotrowski, W."'

Search Results

7. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

10. A highly sensitive lifetime-based luminescent manometer and bi-functional pressure–temperature sensor based on a spectral shift of the R-line of Mn4+ in K2Ge4O9.

13. Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis

15. COVID-19 in patients with Pulmonary Alveolar Proteinosis A European multicenter study

16. Therapeutic decisions regarding initiation of antifibrotic therapy in IPF: a multicenter, prospective cohort study from Poland.

18. Critical evaluation of the thermometric performance of ratiometric luminescence thermometers based on Ba3(VO4)2:Mn5+,Nd3+ for deep-tissue thermal imaging.

19. Understanding the power of luminescence ratiometric thermal history indicators driven by phase transitions: the case of Eu3+ doped LaVO4.

20. Understanding the power of luminescence ratiometric thermal history indicators driven by phase transitions: the case of Eu3+ doped LaVO4.

22. Tunable luminescence thermal stability in YVxAs1−xO4:Eu3+ through the introduction of As5+ ions for remote temperature sensing applications.

25. TGF-β and SMADs mRNA Expression in Pulmonary Sarcoidosis

26. Working group on epidemiology & prevention of the european society of cardiology: Proceedings of meeting held at Shannon May 14th–17th, 1998

27. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

28. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

33. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

34. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study

36. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

37. PDDL+ Planning with temporal pattern databases

41. The role of Cr3+ and Cr4+ in emission brightness enhancement and sensitivity improvement of NIR-emitting Nd3+/Er3+ ratiometric luminescent thermometers.

43. PDDL+ Planning with temporal pattern databases

45. Strong sensitivity enhancement in lifetime-based luminescence thermometry by co-doping of SrTiO3:Mn4+ nanocrystals with trivalent lanthanide ions.

46. Heuristic Planning for PDDL+ domains

47. Innate immune response to viral infections in primary bronchial epithelial cells is modified by the atopic status of asthmatic patients

49. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

50. From quencher to potent activator – Multimodal luminescence thermometry with Fe3+ in the oxides MAl4O7 (M = Ca, Sr, Ba).

Catalog

Books, media, physical & digital resources